NEW YORK, Feb. 20 (GenomeWeb News) - Accelrys said on Friday that it has received a notice from the Nasdaq that the company is not in compliance with the exchange's rules after failing to file its fourth-quarter financial report on time.
To read the full story....
Already have a GenomeWeb or 360Dx account?
.